Contents

Current Drug Targets - Inflammation & Allergy, Volume 3 - Number 2

Preface [Hot topic: Psoriasis (Guest Editor: Giampiero Girolomoni)]

, 3(2): i

Giampiero Girolomoni


DOI: 10.2174/1568010043343921




Epidemiology of Psoriasis

, 3(2): 121 - 128

Luigi Naldi


DOI: 10.2174/1568010043343958




The Psoriasis Genetics as a Model of Complex Disease

, 3(2): 129 - 136

Emiliano Giardina, Cecilia Sinibaldi and Giuseppe Novelli


DOI: 10.2174/1568010043343877




Immunopathogenesis of Psoriasis

, 3(2): 137 - 144

Maki Ozawa and Setsuya Aiba


DOI: 10.2174/1568010043343868




Established Treatments of Psoriasis

, 3(2): 145 - 156

Peter C.M. van de Kerkhof and Wijnand H.P.M. Vissers


DOI: 10.2174/1568010043343967




T-Cell-Targeted Biologicals for Psoriasis

, 3(2): 157 - 161

Christopher E.M. Griffiths


DOI: 10.2174/1568010043343912




Targeting Selectin Functions in the Therapy of Psoriasis

, 3(2): 163 - 168

Michael P. Schon, Claudia Drewniok and W. -Henning Boehncke


DOI: 10.2174/1568010043343895




Chemokines and Chemokine Receptors as Targets in the Therapy of Psoriasis

, 3(2): 169 - 174

Bernhard Homey


DOI: 10.2174/1568010043343840




Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis

, 3(2): 175 - 183

Paolo Gisondi, Emanuela Gubinelli, Barbara Cocuroccia and Giampiero Girolomoni


DOI: 10.2174/1568010043343903




Interleukin-10: An Important Immunoregulatory Cytokine With Major Impact on Psoriasis

, 3(2): 185 - 192

Khusru Asadullah, Robert Sabat, Markus Friedrich, Hans Dieter Volk and Wolfram Sterry


DOI: 10.2174/1568010043343886




Immune Deviation Strategies in the Therapy of Psoriasis

, 3(2): 193 - 198

Kamran Ghoreschi and Martin Rocken


DOI: 10.2174/1568010043343949




New Vitamin D Analogs in Psoriasis

, 3(2): 199 - 204

Karsten Fogh and Knud Kragballe


DOI: 10.2174/1568010043343930




Peroxisome Proliferator-Activated Receptors as New Molecular Targets in Psoriasis

, 3(2): 205 - 211

Stephane Kuenzli and Jean-Hilaire Saurat


DOI: 10.2174/1568010043343976




Histone Deacetylase Inhibitors in Psoriasis Therapy

, 3(2): 213 - 219

Fiona McLaughlin and Nicholas B. La Thangue


DOI: 10.2174/1568010043343859




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science